TREATMENT OF COGNITIVE IMPAIRMENT OF MUCOPOLYSACCHARIDOSIS TYPE IIIA BY INTRATHECAL… Application EP-3827839-A1 European Patent Office 02 Jun 2021
TREATMENT OF COGNITIVE IMPAIRMENT OF MUCOPOLYSACCHARIDOSIS TYPE IIIA BY INTRATHECAL… Application WO-2017015375-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2017